ReviewHealth science reports2026
Association Between Dietary Tea Consumption and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Review in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is a significant global health concern linked with metabolic syndrome, affecting approximately 25% of the global population. It leads to severe liver complications and has limited effective pharmacological treatments. Tea, known for its bioactive compounds such as flavonoids and polyphenols, has been suggested to potentially mitigate NAFLD through antioxidant, anti-inflammatory, and lipid-lowering effects. This systematic review assessed the association between Dietary Tea Consumption and NAFLD. Methods: We conducted a comprehensive search across PubMed, Embase, and Web of Science, including all literature up to July 1, 2025. We included studies examining the impact of tea consumption on adults diagnosed with NAFLD. Data were synthesized using random-effects meta-analysis, with heterogeneity assessed by Results: Out of 5461 records screened, 15 studies that met the inclusion criteria comprising 1,398,936 participants. The pooled odds ratio (OR) for tea consumption associated with NAFLD risk was 0.782 (95% CI: 0.549-1.113), indicating a non-significant association. Significant heterogeneity ( Conclusion: Tea consumption maybe associated with and reduced NAFLD. Further research is needed to clarify these findings and to establish evidence-based dietary recommendations for NAFLD management, considering the global prevalence and health burden of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.